Related Experiment Video
Updated: Aug 17, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure
Y F Cheung1, George W Chay, Clement S W Chiu
1Department of Paediatrics and Adolescent Medicine, Division of Paediatric Cardiology, Grantham Hospital, The University of Hong Kong, Aberdeen, Hong Kong, People's Republic of China. xfcheung@hkucc.hku.hk
Insights
Chronic anticoagulation may not be necessary for most ethnic Chinese Fontan patients. However, it may be considered for individuals with specific risk factors like dilated right atrium or arrhythmias.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Cardiovascular Surgery
Background:
- The necessity of long-term anticoagulation for Fontan patients is debated.
- This study investigates thromboembolic complication rates in relation to anticoagulation strategies post-Fontan procedure.
Purpose of the Study:
- To determine the prevalence of thromboembolic complications in ethnic Chinese Fontan patients.
- To evaluate the effectiveness of different long-term anticoagulation strategies.
Main Methods:
- Retrospective review of clinical outcomes, anticoagulation strategies, and thromboembolic events.
- Analysis of 102 ethnic Chinese patients who underwent the Fontan procedure between 1980 and 2002.
Main Results:
- Early and late mortality rates were 10.8% and 5.8%, respectively, unrelated to thromboembolism.
- Thromboembolic complications occurred in 4.5% of survivors, irrespective of warfarin use.
- Patients without chronic anticoagulation showed no increased risk of thromboembolism compared to those on warfarin.
Conclusions:
- Chronic anticoagulation may not be required for the majority of ethnic Chinese Fontan patients.
- Consideration for anticoagulation may be warranted in patients with a dilated right atrium, cardiac arrhythmias, or residual right-to-left shunts.
Background:
The necessity for chronic anticoagulation of Fontan patients remains controversial. We determined the prevalence of thromboembolic complications after the Fontan procedure in relation to different long-term anticoagulation strategies.
Methods:
The clinical outcomes, postoperative anticoagulation strategies and occurrence of thromboembolic complications in 102 ethnic Chinese patients who had undergone Fontan procedure between 1980 and 2002 were reviewed.
Results:
The early and late surgical mortalities, all unrelated to thromboembolism, were 10.8% (11/102) and 5.8% (6/104), respectively. Of the 85 survivors, 46 (54%) were maintained on long-term warfarin therapy, 8 (9%) on aspirin prophylaxis while 31 (37%) were not on chronic anticoagulation. Four (4.5%) patients, two with and two without warfarin prophylaxis, developed thromboembolic complications at 0.14 to 7.7 years after the Fontan procedure (0.74%/patient-year). Three had a grossly dilated right atrium after atriopulmonary connection, two of whom had atrial fenestrations. The other had atrial tachycardia. Freedom from development of thromboembolic complications (mean+/-S.E.) at 1, 5 and 10 years after surgery was 97+/-19%, 96+/-2.5% and 92+/-4.2%, respectively. When compared with those on long-term warfarin therapy, patients without chronic anticoagulation were followed-up longer (p=0.001), more likely to have undergone atriopulmonary connection (p<0.001), less likely to have fenestrations (p=0.02) and cardiac arrhythmias (p=0.02) but not predisposed to increased risk of thromboembolism (p=1.00).
Conclusion:
The study supports the contention that chronic anticoagulation may not be required for majority of ethnic Chinese Fontan patients. Nonetheless, it may perhaps be considered in those with grossly dilated right atrium, cardiac arrhythmias and residual right-to-left shunts.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management